[Federal Register Volume 67, Number 212 (Friday, November 1, 2002)]
[Notices]
[Page 66646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-27884]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Women's Health Initiative Subcommittee of the Advisory Committee 
for Reproductive Health Drugs; Notice of Postponement of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is postponing the 
meeting of the Women's Health Initiative Subcommittee of the Advisory 
Committee for Reproductive Health Drugs scheduled for November 12 and 
13, 2002. The meeting was announced in the Federal Register of October 
21, 2002 (67 FR 64651). FDA's Center for Drug Evaluation and Research 
is going to evaluate additional data relevant to the topic. Future 
meeting dates will be announced in the Federal Register.

FOR FURTHER INFORMATION CONTACT: Jayne E. Peterson, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or 
e-mail: [email protected], or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
12537. Please call the Information Line for up-to-date information on 
this meeting.

    Dated: October 24, 2002.
LaJuana D. Caldwell,
Acting Senior Associate Commissioner for External Relations.
[FR Doc. 02-27884 Filed 10-31-02; 8:45 am]
BILLING CODE 4160-01-S